ImportantUpdates
Company approved financial results for the quarter and year with an unmodified auditor's opinion, despite regulatory restraint on a planned business restructuring.
Par Drugs and Chemicals LimitedPAR · Filed with the exchange
The Board approved new investments up to ₹90 Cr and renewed a banking facility of ₹1.61 Cr.
No comments yet. Be the first.